Publications

My publications cover the range of areas I have worked in, including the health economics of cancer care, occupational therapy rehabilitation and breast cancer clinical practice guidelines.

  1. Jollife L, Christie LJ, Fearn N, Nohrenberg M, Liu R, Williams JF, Parsons MW, Pearce A. (2024). A systematic review of discrete choice experiments in stroke rehabilitationTopics in Stroke Rehabilitation. DOI: 10.1080/10749357.2024.2312641
  2. Howard K, Norris S, Salisbury A, Pearce A, Hay L, Stapleton B, Lean C, Last A, Kwedza R, White K, Rushton S. (2024). Women’s preferences for hypofractionated radiation therapy for treatment of early-stage breast cancer: a discrete choice experimentInternational Journal of Radiation Oncology, Biology, Physics. Published online 16th Dec 2023.
  3. Christe LJ, Rendell R, Fearn N, Descallar J, McCluskey A, Pearce A, Wong L, Lovarini M (2023). Increasing the delivery of upper limb constraint-induced movement therapy programs for stroke and brain injury survivors: evaluation of the ACTIveARM ProjectDisability and Rehabilitation. Published online 22nd Dec 2023
  4. van Til J, Pearce A, Ozdemir S, Hollin I, Peay H, Wu A, Ostermann J, Deal K, Craig B (2023). Role preferences in medical decision making: Relevance and implications for health preference research. The Patient, Published online 24th Oct 2023.
  5. Pearce A, Scarfe J, Jones M, Cashmore A, Milat A, Barnes L, Passey M (2023). Study protocol of an economic evaluation embedded in the Midwives and Obstetricians Helping Mothers to Quit Smoking (MOHMQuit) trialBMC Health Services Research, 23, 939.
  6. Ortega-Ortega M, Hanly P, Pearce A, et al. Projected impact on labor productivity costs of cancer-related premature mortality in Europe 2018-2040Applied Health Economics and Health Policy. 8th Aug 2023.
  7. Venchiarutti RL, Pearce A, Mathers L, Dawson T, Ch’ng S, Shannon K, Clark JR, Palme CE. Travel-associated cost savings to patients and the health system through provision of specialist head and neck surgery outreach clinics in rural New South Wales, Australia. (2023). Australian Journal of Rural Health, 00:1-12
  8. Henry G, Webb A, Galea C, Pearce A, Balde I, Garrity F, Marmont S, Espie J, Badawi N, McIntyre S. (2023). Out of pocket costs for families and people living with cerebral palsy in Australia. PlosOne. 20th July 2023
  9. De Camargo Cancela M, Leandro Bezerra de Souza D, Felipe Leite Martins, L, Borges L, Orlando Schilithz A, Hanly P, Sharp L, Pearce A, Soejorataram I (2023). Can the sustainable development goals for cancer be met in Brazil? A population-based study. Frontiers in Oncology. 10 January 2023
  10. De Camargo Cancela M, Dos Santos JEM, Borges Lopes de Souza L, Felipe Leite Martins L, Bezerra de Souza D, Barchuk A, Hanly P, Sharp L, Soerjomataram I, Pearce A. The economic impact of cancer mortality among working age individuals in Brazil from 2001 to 2030Cancer Epidemiology, 86: 102438
  11. Barnes L, Longman J, Adams C, Paul C, Atkins L, Bonevski B, Cashmore A, Twyman L, Bailie R, Pearce A, Barker D, Milat A, Dorling J, Nicholl M, Passey M. (2022). The MOHMQuit (Midwives and Obstetricians Helping Mothers to Quit Smoking) Trial: protocol for a stepped-wedge implementation trial to improve best practice smoking cessation support in public antenatal care servicesImplementation Science. 17:79
  12. Faaij M, Schoormans D, Pearce A. (2022). Work, daily activities and leisure after cancerEuropean Journal of Cancer Care. 31(4)e13596
  13. Christie L, Fearn N, McCluskey A, Lovarini M, Rendell R, Pearce A. (2022). Cost effectiveness of constraint induced movement therapy implementation in neurorehabilitation: The ACTIveARM Project. Pharmacoeconomics Open. 6(3):437-450
  14. Goldsbury DE, Feletto E, Weber MF, Haywood P, Pearce A, Lew JB, Worthington J, He E, Steinberg J, O’Connell DL, Canfell K. (2022). Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia. PLOS One. 16(11):e0260088
  15. Hassett L, Jennings M, Brady B, Pinheiro M, Haynes A, Sidhu B, Christie L, Dennis S, Pearce A, Howard K, Greaves C & Sherrington C. (2022). Brief physical activity counselling by physiotherapists (BEHAVIOUR): protocol for an effectiveness-implementation hybrid type II cluster randomised controlled trialImplementation Science Communications: 3(39)
  16. Sigurdson S, Harrison M, Pearce A, Richardson H, Zaza K, Brundage M. (2022). One fraction size does not fit all: Patient preferences for hypofractionated radiation therapy from a discrete choice experimentPractical Radiation Oncology 12(1):e24-e33. 
  17. Marinovich L, Wylie E, Lotter W, Pearce A, Carter S, Lund H, Waddell A, Kim J, Pereira G, Lee C, Zackrisson S, Brennan M, Houssami N. (2022). Artificial intelligence (AI) to enhance breast cancer screening: protocol for a population-based cohort study of cancer detectionBMJ Open; 12 e054005.
  18. Shaw J, Allison K, Cuddy J, Lindsay T, Grimison P, Shepherd H, Butow P, Shaw T, Baychek K, The ADAPT Program Group, Kelly B. (2022). Development, acceptability and uptake of an online communication skills education program targeting challenging conversations for oncology health professionals related to identifying and responding to anxiety and depression. BMC Health Services Research. 22(132). 
  19. Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L. (2021). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018International Journal of Cancer. 150(4): 580-593
  20. Gelfand A, Sou J, Sawatzky R, Prescott K, Pearce A, Anis A H, Lee C, Zhang W. (2021). Valuation of lost productivity in caregivers: a validation study. Frontiers in Psychology (Organizational Psychology section). 12:727871. doi: 10.3389/fpsyg.2021.727871
  21. Williams J, Pearce A, Smith A. (2021). A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectivenessPsycho-Oncology. 308): 1185– 1195
  22. Yu A, Street D, Viney R, Goodall S, Pearce A, Haywood Ph, Haas M, Battaglini E, Goldstein D, Timmins H, Park S. (2021). Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences. Supportive Care in Cancer. 296379–6387.
  23. Yim J, Shaw J, Viney R, Arora S, Ezendam N, Pearce A. (2021). Investigating the association between self-reported comorbid anxiety and depression and health service use in cancer survivorsPharmacoeconomics. 39, pages681–690.
  24. Pearce A, Harrison M, Watson V, Street D, Howard K, Bansback N, Bryan S. (2021). Respondent understanding in discrete choice experiments: A scoping reviewThe Patient: 14, 17-53.
  25. Hanly P, Ortega Ortega M, Pearce A, Soerjomataram I, Sharp L. (2020). Advances in the methodological approach to friction period estimation: A European perspectiveSocial Science and Medicine: 264, p. 113289.
  26. Geerligs L, Shepherd H, Putow P, Shaw J, Masya L, Cuddy J, ADAPT Program Group, Ranking N. (2021). What factors influence organisational readiness for change? Implementation of the Australian clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP)Supportive Care in Cancer. 29(6):3235-3244
  27. Manipis K, Goodall S, Hanly P, Viney R, Pearce A (2020). Employer survey to estimate the productivity friction periodEuropean Journal of Health Economics: 22: 255-266
  28. Mols F, Tomalin B, Pearce A, Kaambwa B, Koczwara B. (2020). Financial toxicity and employment status in cancer survivors. A systematic literature review. Supportive Care in Cancer: 28, 5693-5708
  29. Pearce A, Mulhern B, Watson V, Viney R. (2020). How are debriefing questions used in health discrete choice experiments? An online survey. Value in Health: 23(3), 289-293
  30. Smith A, Bamgboje-Ayodele A, Butow P, Klein B, Turner J, Sharpe L, Fardell J, Beatty L, Pearce A, Thewes B, Beith J, Costa D, Community Advisory Group Members and Girgis A. (2020). Development and usability evaluation of an online self-management intervention for fear of cancer recurrence (iConquerFear)Psycho-Oncology:29(1)
  31. Geerligs L, Shepherd H, Rankin N, et al. (2020). The value of real-world testing: a qualitative feasibility study to explore staff and organisational barriers and strategies to support implementation of a clinical pathwya for the management of anxiety and depresssion in adult cancer patients. Pilot and Feasibility Studies, 6(109). 
  32. Barchuk A, Bespalov A, Huhtala H, Chimed T, Belyaev A, Moore M, Anttila A, Auvinen A, Pearce A, Soerjomataram I. (2019). Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001-2030Scandinavian Journal of Public Health: Early online. 
  33. Pearce A, Tomalin B, Kaambwa B, Horevoorts N, Duijts S, Mols F, van de Poll-Franse L, Koczwara B. (2019). Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivorsJournal of Cancer Survivorship: 13:10-20. 
  34. Pearce A, Sharp L, Hanly P, Barchuk A, Bray F, de Camargo Cancel M, Gupta P, Meheus F, Qiao YL, Sitas F, Wang SM, Soerjomataram I (2018). Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China and South Africa (BRICS): A population-based comparison. Cancer Epidemiology: 53, 27-34.
  35. Butow P, Shaw J, Shepherd H, et al, and The ADAPT Program Group (2018). Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): Study protocol of a cluster randomised controlled trial. BMC Cancer, 18(1077). 
  36. Shaw J, Pearce A, Lopez AL, Price M. (2018). Clinical anxiety disorders in the context of cancer: a scoping review of impact on resource use and health care costs. European Journal of Cancer Care, 27(5).
  37. Pearce A, Haas M, Viney R, Pearson SA, Haywood P, Brown C, Ward R (2017). Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLOS One, 12(10): e0184360.
  38. Hanly P, Pearce A, Sharp L (2017). Cancer and productivity loss in the Irish economy: An employer’s perspectiveIrish Journal of Management, 36(1): 5-20
  39. Thomas AA, Pearce A, O’Neill C, Molcho M, Sharp L. (2016). Urban-rural differences in cancer-directed surgery and survival of patients with non-small cell lung cancerJournal Epidemiology and Community Health.
  40. Pearce A, Bradley C, Hanly P, O’Neill C, Thomas AA, Molcho M, Sharp L. (2016). Projecting productivity losses for cancer-related mortality 2011 – 2030BMC Cancer. 16:804
  41. Thomas AA, Pearce A, Sharp L, Gardiner RA, Chambers S, Aitken JA, Molcho M, Baade P. (2016). Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks. Asia-Pacific Journal of Clinical Oncology.
  42. Pearce A, Ryan F (joint first author), Drummond F, Thomas AA, Timmons A, Sharp L (2015). Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysisSupportive Care in Cancer. Early online 06 August 2015.
  43. Pearce A, Hanly P, Timmons A, Walsh PM, O’Neill C, O’Sullivan E, Gooberman-Hill R, Thomas AA, Gallagher P, Sharp L (2015). Productivity losses associated with head and neck cancer using the Human Capital and Friction Cost approachesApp Health Economics and Health Policy. Early online 19 February 2015.
  44. Pearce AM, Timmons A, O’Sullivan E, Gallagher P, Gooberman-Hill R, Thomas AA, Molcho M, Butow P, Sharp L (2015). Long-term workforce participation patterns following head and neck cancerJournal of Cancer Survivorship, 9(1):30-39.
  45. Pearce A, Haas M, Viney R, Haywood P, Pearson SA, van Gool K, Srasuebkul P, Ward R (2014). Can administrative data be used to measure chemotherapy side effects? Expert Rev Pharmacoecon Outcomes Res. Early online 1-8.
  46. Sharp L, Deady S, Gallagher P, Molcho M, Pearce A, Thomas AA, Timmons A, Comber H (2014). The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care. BMC Cancer. 14:767
  47. Thomas AA, Gallagher P, O’Ceilleachair A, Pearce A, Sharp L, Molcho M (2014). Distance from treating hospital and colorectal cancer survivors’ quality of life: a gendered analysisSupportive Care in Cancer. 23(3):741-751.
  48. Hanly P, Pearce AM, Sharp L (2014). The cost of premature cancer-related mortality: a review and assessment of the evidenceExpert Review of Pharmacoeconomics and Outcomes Research. 14(3), 355-377.
  49. Thomas AA, Timmons A, Molcho M, Pearce A, Gallagher P, Butow P, O’Sullivan E, Gooberman-Hill R, O’Neill C, Sharp L (2014). Quality of life in urban and rural settings: A study of head and neck cancer survivorsOral Oncology. 50(7), 679-682.
  50. Pearce A, Haas M, Viney R (2013). Are the true impacts of adverse events considered in economic models of antineoplastic drugs? A systematic review. Journal of Applied Health Economics and Health Policy. 11(6), 619-637.
  51. Noushi F, Spillane AJ, Uren RF, Cooper R, Allwright S, Snook KL, Gillet D, Pearce A, Gebski V (2013). High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphy. European Journal of Surgical Oncology. 39(10), 1053-1060
  52. Pearce A, Van Gool K, Haywood P, Haas M (2013).  Delays in access to affordable medicines – putting policy into perspective: Authors’ responseAustralian Health Review. 38(1), 16-17.
  53. Pearce A, Van Gool K, Haywood P, Haas M (2012).  Delays in access to affordable medicines – putting policy into perspective. Australian Health Review, 36(4), 412-418
  54. Pearce A, Smead J, Cameron I (2012).  Retrospective cohort study of accident outcomes for individuals who have successfully undergone driver assessment following strokeAustralian Occupational Therapy Journal. 59(1), 56-62